Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03441360
Title Study to Assess Safety and Preliminary Activity of Eribulin Mesylate in Pediatric Subjects With Relapsed/Refractory Rhabdomyosarcoma (RMS), Non-rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) and Ewing Sarcoma (EWS)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Eisai Inc.
Indications

Ewing sarcoma

sarcoma

rhabdomyosarcoma

Therapies

Eribulin

Age Groups: adult | child
Covered Countries USA


No variant requirements are available.